Structural and biochemical investigations of the thyroid hormone receptor and v-erbA oncoprotein
by Slivka, Eric John, Ph.D., UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, 2009, 73 pages; 3352469

Abstract:

The thyroid hormone receptor is a ligand-dependent transcription factor crucial for the regulation of a wide variety of processes involved in metabolism, differentiation, and development. While much has been learned about the structure of the thyroid hormone receptor and the molecular determinants of hormone binding, a complete understanding of these determinants has not yet been obtained.

In order to better understand the molecular determinants of hormone binding in the thyroid hormone receptor, v-erbA, a naturally occurring form of the receptor found in a retrovirus, was used as a platform for mutational studies. The use of v-erbA, which is severely compromised in its ability to bind thyroid hormone and activate transcription, provided a convenient and natural template upon which targeted mutations could be made.

Mutational analysis on ligand binding domain constructs determined that the addition of a missing helix (Helix 12) near the C-terminus of v-erbA was insufficient to restore ligand binding ability to the receptor, but an additional single point mutation, S395F, near the same location was capable of restoring hormone affinity to within ten-fold of that of wild-type thyroid hormone receptor. Protein stability assays based on protease degradation and thermal denaturation also demonstrated this constructs improved stability over other v-erbA constructs.

Transcriptional data obtained using full-length constructs in transient transfection assays demonstrated that the S395F mutation significantly enhanced the ability of v-erbA to activate transcription in the presence of hormone. While both v-erbA and v-erbA + Helix 12 constructs not only failed to activate transcription in the presence of hormone but maintained repression seen in the absence of hormone, the v-erbA + Helix 12 S395 F mutant activated transcription even beyond the level seen with wild-type thryroid hormone receptor.

 
AdviserRobert J. Fletterick
SchoolUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
SourceDAI/B 70-04, p. , May 2009
Source TypeDissertation
SubjectsMolecular biology; Biochemistry
Publication Number3352469
Adobe PDF Access the complete dissertation:
 

» Find an electronic copy at your library.
  Use the link below to access a full citation record of this graduate work:
  http://gateway.proquest.com/openurl%3furl_ver=Z39.88-2004%26res_dat=xri:pqdiss%26rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation%26rft_dat=xri:pqdiss:3352469
  If your library subscribes to the ProQuest Dissertations & Theses (PQDT) database, you may be entitled to a free electronic version of this graduate work. If not, you will have the option to purchase one, and access a 24 page preview for free (if available).

About ProQuest Dissertations & Theses
With over 2.3 million records, the ProQuest Dissertations & Theses (PQDT) database is the most comprehensive collection of dissertations and theses in the world. It is the database of record for graduate research.

The database includes citations of graduate works ranging from the first U.S. dissertation, accepted in 1861, to those accepted as recently as last semester. Of the 2.3 million graduate works included in the database, ProQuest offers more than 1.9 million in full text formats. Of those, over 860,000 are available in PDF format. More than 60,000 dissertations and theses are added to the database each year.

If you have questions, please feel free to visit the ProQuest Web site - http://www.proquest.com - or call ProQuest Hotline Customer Support at 1-800-521-3042.